|
C14ORF129 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.652400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.469000E-01 |
| Normal-vs-Stage2 |
9.219200E-01 |
| Normal-vs-Stage3 |
8.032800E-01 |
| Normal-vs-Stage4 |
7.153200E-01 |
| Stage1-vs-Stage2 |
7.582400E-01 |
| Stage1-vs-Stage3 |
7.853800E-01 |
| Stage1-vs-Stage4 |
4.057600E-01 |
| Stage2-vs-Stage3 |
9.252000E-01 |
| Stage2-vs-Stage4 |
7.009000E-01 |
| Stage3-vs-Stage4 |
5.839400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.378400E-01 |
| Normal-vs-AfricanAmerican |
8.657800E-01 |
| Normal-vs-Asian |
2.520800E-01 |
| Caucasian-vs-AfricanAmerican |
7.348000E-01 |
| Caucasian-vs-Asian |
7.182500E-02 |
| AfricanAmerican-vs-Asian |
3.414200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.496200E-01 |
| Normal-vs-Female |
4.359200E-01 |
| Male-vs-Female |
1.876350E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.423600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.191200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.447600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.059600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.539980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.333200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.275800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.870000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.234370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.917430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.551800E-01 |
| Classical-VS-Follicular |
2.017600E-03 |
| Classical-VS-Other |
9.690200E-02 |
| Classical-VS-Normal |
1.551620E-01 |
| Tall-VS-Follicular |
5.275700E-02 |
| Tall-VS-Other |
1.197440E-01 |
| Tall-VS-Normal |
3.026000E-01 |
| Follicular-VS-Other |
5.905200E-01 |
| Follicular-VS-Normal |
1.430240E-01 |
| Other-VS-Normal |
1.231800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.699800E-01 |
| Normal-vs-N1 |
2.522200E-01 |
| N0-vs-N1 |
5.682600E-01 |
|
|
